Anna-Liisa Kautio

488 total citations
9 papers, 380 citations indexed

About

Anna-Liisa Kautio is a scholar working on Oncology, Dermatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anna-Liisa Kautio has authored 9 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 3 papers in Dermatology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anna-Liisa Kautio's work include Cancer Treatment and Pharmacology (8 papers), Prostate Cancer Treatment and Research (3 papers) and Chemotherapy-related skin toxicity (3 papers). Anna-Liisa Kautio is often cited by papers focused on Cancer Treatment and Pharmacology (8 papers), Prostate Cancer Treatment and Research (3 papers) and Chemotherapy-related skin toxicity (3 papers). Anna-Liisa Kautio collaborates with scholars based in Finland. Anna-Liisa Kautio's co-authors include Tiina Saarto, Maija Haanpää, Eija Kalso, Hannu Kautiainen, Arto Leminen, Hannu Haapasalo, Aki Hietaharju, M Koskinen, Timo Marttila and Vesa Kataja and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Pain and Symptom Management and Supportive Care in Cancer.

In The Last Decade

Anna-Liisa Kautio

9 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna-Liisa Kautio Finland	5	297	153	137	88	44	9	380
P Tredici Italy	7	231 0.8×	38 0.2×	110 0.8×	48 0.5×	70 1.6×	9	411
Tiffany Li Australia	15	425 1.4×	198 1.3×	89 0.6×	129 1.5×	67 1.5×	38	545
Ching Hsu United States	10	107 0.4×	3 0.0×	130 0.9×	20 0.2×	37 0.8×	23	356
Paola Venturino Italy	10	230 0.8×	23 0.2×	49 0.4×	20 0.2×	140 3.2×	15	376
Teruo Yamauchi Japan	10	109 0.4×	20 0.1×	34 0.2×	4 0.0×	82 1.9×	23	310
Kazumasa Suzuki Japan	11	79 0.3×	6 0.0×	36 0.3×	16 0.2×	22 0.5×	37	416
Meng‐Ting Peng Taiwan	9	106 0.4×	37 0.2×	26 0.2×	8 0.1×	39 0.9×	21	280
A Mangiameli Italy	8	48 0.2×	20 0.1×	71 0.5×	5 0.1×	35 0.8×	33	308
A. Bertolini Italy	10	112 0.4×	6 0.0×	20 0.1×	24 0.3×	73 1.7×	37	310
Amanda Quebe United States	7	66 0.2×	5 0.0×	31 0.2×	75 0.9×	6 0.1×	16	318

Countries citing papers authored by Anna-Liisa Kautio

Since Specialization

Citations

This map shows the geographic impact of Anna-Liisa Kautio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna-Liisa Kautio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna-Liisa Kautio more than expected).

Fields of papers citing papers by Anna-Liisa Kautio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna-Liisa Kautio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna-Liisa Kautio. The network helps show where Anna-Liisa Kautio may publish in the future.

Co-authorship network of co-authors of Anna-Liisa Kautio

This figure shows the co-authorship network connecting the top 25 collaborators of Anna-Liisa Kautio. A scholar is included among the top collaborators of Anna-Liisa Kautio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna-Liisa Kautio. Anna-Liisa Kautio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Kellokumpu‐Lehtinen, Pirkko‐Liisa, Timo Marttila, Antti Jekunen, et al.. (2020). Biweekly Cabazitaxel Is a Safe Treatment Option for Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients After Docetaxel – A Final Analysis of the Prosty II Trial. Anticancer Research. 40(12). 6915–6921. 3 indexed citations

Kellokumpu‐Lehtinen, Pirkko‐Liisa, Timo Marttila, Antti Jekunen, et al.. (2016). Biweekly cabazitaxel as a safe treatment option for metastatic castration resistant prostate cancer (mCRPC) patients post-docetaxel: Final analysis of Prosty II trial.. Journal of Clinical Oncology. 34(15_suppl). e16523–e16523. 2 indexed citations

Marttila, Timo, et al.. (2015). Biweekly cabazitaxel as post-docetaxel treatment for metastatic castration resistant prostate cancer (mCRPC): Findings from an early safety analysis of the Prosty II trial.. Journal of Clinical Oncology. 33(7_suppl). 276–276. 2 indexed citations

Kautio, Anna-Liisa. (2012). Chemotherapy-induced neuropathy: prevention and treatment. Työväentutkimus Vuosikirja. 2 indexed citations

Kautio, Anna-Liisa, Maija Haanpää, Hannu Kautiainen, et al.. (2011). Oxaliplatin scale and National Cancer Institute-Common Toxicity Criteria in the assessment of chemotherapy-induced peripheral neuropathy.. PubMed. 31(10). 3493–6. 27 indexed citations

Koskinen, M, Anna-Liisa Kautio, Maija Haanpää, et al.. (2011). Intraepidermal nerve fibre density in cancer patients receiving adjuvant chemotherapy.. PubMed. 31(12). 4413–6. 42 indexed citations

Kautio, Anna-Liisa, Maija Haanpää, Hannu Kautiainen, Eija Kalso, & Tiina Saarto. (2010). Burden of chemotherapy-induced neuropathy—a cross-sectional study. Supportive Care in Cancer. 19(12). 1991–1996. 65 indexed citations

Kautio, Anna-Liisa, Maija Haanpää, Arto Leminen, et al.. (2009). Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms.. PubMed. 29(7). 2601–6. 72 indexed citations

Kautio, Anna-Liisa, Maija Haanpää, Tiina Saarto, & Eija Kalso. (2007). Amitriptyline in the Treatment of Chemotherapy-Induced Neuropathic Symptoms. Journal of Pain and Symptom Management. 35(1). 31–39. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact